SI0885013T1 - - Google Patents

Info

Publication number
SI0885013T1
SI0885013T1 SI9730186T SI9730186T SI0885013T1 SI 0885013 T1 SI0885013 T1 SI 0885013T1 SI 9730186 T SI9730186 T SI 9730186T SI 9730186 T SI9730186 T SI 9730186T SI 0885013 T1 SI0885013 T1 SI 0885013T1
Authority
SI
Slovenia
Prior art keywords
pox
parapox
inducers
multipotent
attenuated
Prior art date
Application number
SI9730186T
Other languages
English (en)
Inventor
Anton Mayr
Original Assignee
Anton Mayr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anton Mayr filed Critical Anton Mayr
Publication of SI0885013T1 publication Critical patent/SI0885013T1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/76Viruses; Subviral particles; Bacteriophages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/275Poxviridae, e.g. avipoxvirus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24211Parapoxvirus, e.g. Orf virus
    • C12N2710/24232Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SI9730186T 1996-04-15 1997-04-14 SI0885013T1 (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19614810 1996-04-15
PCT/DE1997/000761 WO1997038724A1 (de) 1996-04-15 1997-04-14 Neue indikationen für die verwendung von multipotenten paramunitätsinducern aus attenuierten, nicht-immunogenen pockenviren oder parapockenviren als arzneimittel

Publications (1)

Publication Number Publication Date
SI0885013T1 true SI0885013T1 (lt) 2001-12-31

Family

ID=7791302

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730186T SI0885013T1 (lt) 1996-04-15 1997-04-14

Country Status (20)

Country Link
US (1) US6162600A (lt)
EP (1) EP0885013B1 (lt)
JP (1) JP3568208B2 (lt)
KR (1) KR100302994B1 (lt)
CN (1) CN1165343C (lt)
AT (1) ATE203678T1 (lt)
AU (1) AU706729B2 (lt)
BR (1) BR9708679A (lt)
CA (1) CA2251690C (lt)
DE (2) DE19780300D2 (lt)
DK (1) DK0885013T3 (lt)
ES (1) ES2125846T3 (lt)
GR (1) GR3037049T3 (lt)
HU (1) HU224308B1 (lt)
NO (1) NO322176B1 (lt)
NZ (1) NZ332243A (lt)
PL (1) PL329353A1 (lt)
PT (1) PT885013E (lt)
SI (1) SI0885013T1 (lt)
WO (1) WO1997038724A1 (lt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004002A2 (de) * 2000-07-11 2002-01-17 Bayer Aktiengesellschaft Verwendung von stämmen des parapoxvirus ovis zur herstellung von antiviralen arzneimitteln und arzneimitteln gegen krebs
DE10122233A1 (de) * 2000-07-11 2002-01-24 Bayer Ag Verwendung von Stämmen des Parapoxvirus ovis gegen Organfibrosen
US6632647B2 (en) * 2000-07-11 2003-10-14 Bayer Aktiengesellschaft Use of strains of parapoxvirus ovis against organ fibrosis
AU2002362072A1 (en) 2001-12-07 2003-06-23 Board Of Regents The University Of Texas System Use a parapox b2l protein to modify immune responses to administered antigens
CN1984666A (zh) * 2004-07-13 2007-06-20 爱库里斯股份有限两合公司 与其他抗病毒剂联合治疗hiv/aids的副痘病毒
DE102004045758A1 (de) * 2004-09-21 2006-04-06 Toximed Gmbh Pharmazeutischer Wirkstoff gegen das HIV-Syndrom
DE102005027956B4 (de) * 2005-06-16 2009-10-22 Mayr, Anton, Prof. Dr. Dr. h.c. mult. Hochattenuierte Poxvirusstämme, Verfahren zu ihrer Herstellung und deren Verwendung als Paramunitätsinducer oder zur Herstellung von Vektor-Vakzinen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3504940C2 (de) * 1984-02-17 1997-11-06 Bayer Ag Multipotente Paramunitätsmediatoren, Verfahren zu ihrer Herstellung und diese Mediatoren enthaltende Arzneimittel
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
DE4405841C1 (de) * 1994-02-23 1995-01-05 Mayr Anton Prof Dr Med Vet Dr Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
NO984782L (no) 1998-12-15
WO1997038724A1 (de) 1997-10-23
PT885013E (pt) 2002-01-30
PL329353A1 (en) 1999-03-29
EP0885013B1 (de) 2001-08-01
DE19780300D2 (de) 1999-06-17
NO322176B1 (no) 2006-08-21
JP2000501114A (ja) 2000-02-02
ES2125846T3 (es) 2001-12-16
KR20000005479A (ko) 2000-01-25
CA2251690C (en) 2005-11-08
US6162600A (en) 2000-12-19
NO984782D0 (no) 1998-10-14
AU706729B2 (en) 1999-06-24
BR9708679A (pt) 2000-01-04
AU2885897A (en) 1997-11-07
HUP9901299A3 (en) 2000-03-28
EP0885013A1 (de) 1998-12-23
CN1215996A (zh) 1999-05-05
GR3037049T3 (en) 2002-01-31
CA2251690A1 (en) 1997-10-23
DK0885013T3 (da) 2001-11-05
JP3568208B2 (ja) 2004-09-22
KR100302994B1 (ko) 2001-11-30
DE59704194D1 (de) 2001-09-06
CN1165343C (zh) 2004-09-08
HUP9901299A2 (hu) 1999-07-28
HU224308B1 (hu) 2005-07-28
NZ332243A (en) 2000-10-27
ES2125846T1 (es) 1999-03-16
ATE203678T1 (de) 2001-08-15

Similar Documents

Publication Publication Date Title
BG105396A (en) Utilisation of dialkylfumarates
IL157504A0 (en) Oncolytic virus therapy
AU144992S (en) Bottle
MY141415A (en) Therapeutic combination containing interferon
EP0680525A1 (en) FIBERS.
GB2333453A (en) Colostrinin and uses thereof
SI0885013T1 (lt)
ES2176216T3 (es) Particulas de ceramica y su preparacion.
IT8619529A0 (it) Procedimento per combattare particelle di ferro e per la successiva frammentazione del nastro di ferro compattato, e dispositivo per attuare detto procedimento.
ZA855224B (en) Pyrrol-1-ylphenyldihydropyridazinones,their preparation and their use
ZA923935B (en) New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
GB2137089B (en) Pyrethroid-containing pharmaceutical compositions
EP0419964B1 (de) Eisenoxidrot- und Eisenoxid-braun-Mikrogranulate, Verfahren zu ihrer Herstellung sowie deren Verwendung.
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
ZA847967B (en) Diarylindane-1,3-diones,their preparation and use
ZA876168B (en) Human low fc epsilon-receptor,the isolation,the recombinant preparation and purification thereof
EP0960216A4 (en) TREATMENT OF HIV INFECTION BY HINDERING THE INTERACTION OF TOPOISOMERASE HOST WITH HIV GAG AND IT
MD916G2 (ro) Unguent pentru tratamentul afecţiunilor dentare
Confavreux et al. Trends in European Multiple Sclerosis Research
SE9403861D0 (sv) Novel medicinal use
IT8844210A0 (it) Sistema per la riduzione della dispersione, per la conservazione e l'uniforme distribuzione del calore nel pentolame da cucina
UA29639A (uk) Протипухлинний засіб
GR1002968B (el) Φαρμακευτικο παρασκευασμα βασιζομενο σε εναιωρημα εμβρυικων κυτταρων με ανοσοδιορθωτικη δραση και μεθοδος θεραπειας ζαχαρωδους διαβητη με τη χρηση αυτου του παρασκευασματος.
RO99844B1 (ro) Medicament pentru tratamentul gripei si virozelor respiratorii
ZA79295B (en) Catalyst,its preparation and use in the polymerisation of butadiene